Sarcoma News

A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice President Joe Biden said today during the plenary session of the American Association for Cancer Research Annual Meeting.

NEW ORLEANS — Filip Janku, MD, PhD, medical oncologist at The University of Texas MD Anderson Cancer Center, spoke to HemOnc Today about the clinical utility of liquid biopsies.

NEW ORLEANS The American Association for Cancer Research will recognize several clinicians and researchers during its annual meeting.

Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent affordable generic cancer drugs from entering the market, according to a forum article published in Blood.

NEW ORLEANS — The HemOnc Today and Healio.com/HemOnc team will present comprehensive live coverage from the American Association for Cancer Research Annual Meeting.

A California billionaire pledged $250 million to create a new venture designed to accelerate advances in cancer treatment.

The FDA today permitted the marketing of PneumoLiner for use with certain laparoscopic power morcellators to isolate uterine tissue that is not suspected to contain cancer in a limited patient population.

ASCO will recognize several researchers and scientists during the society’s annual meeting, scheduled for June 3-7 in Chicago.

The FDA granted orphan drug designation to an affinity enhanced T-cell therapy targeting NY-ESO to treat soft tissue sarcoma.

Clifford A. Hudis, MD, FACP, has been named the next CEO of ASCO.